Literature DB >> 3264051

Epidemiology of focal and generalized dystonia in Rochester, Minnesota.

J G Nutt1, M D Muenter, A Aronson, L T Kurland, L J Melton.   

Abstract

The epidemiology of generalized and focal dystonias was investigated in the Rochester, Minnesota, population over the period 1950-1982. The crude incidence of generalized dystonia was 2 per million persons per year, and for all focal dystonias combined, 24 per million per year. The crude prevalence rate was 34 per million persons for generalized dystonia and 295 per million persons for all focal dystonias. Torticollis was the most common focal dystonia; essential blepharospasm, oromandibular dystonia, spasmodic dysphonia, and writer's cramp were less common and had roughly equal incidence and prevalence rates.

Entities:  

Mesh:

Year:  1988        PMID: 3264051     DOI: 10.1002/mds.870030302

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  91 in total

1.  "Visual sensory trick" in patient with cervical dystonia.

Authors:  Chan-Nyoung Lee; Mi-Yeon Eun; Do-Young Kwon; Moon Ho Park; Kun-Woo Park
Journal:  Neurol Sci       Date:  2011-11-10       Impact factor: 3.307

2.  Dystonia.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

Review 3.  The genetics of idiopathic torsion dystonia.

Authors:  N A Fletcher
Journal:  J Med Genet       Date:  1990-07       Impact factor: 6.318

Review 4.  The dystonias.

Authors:  C D Marsden; N P Quinn
Journal:  BMJ       Date:  1990-01-20

Review 5.  Genetic and clinical features of primary torsion dystonia.

Authors:  Laurie J Ozelius; Susan B Bressman
Journal:  Neurobiol Dis       Date:  2010-12-17       Impact factor: 5.996

Review 6.  Botulinum toxin type A versus anticholinergics for cervical dystonia.

Authors:  J Costa; C Espírito-Santo; A Borges; J J Ferreira; M Coelho; C Sampaio
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

7.  Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up.

Authors:  J J M Kruisdijk; J H T M Koelman; B W Ongerboer de Visser; R J de Haan; J D Speelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-21       Impact factor: 10.154

8.  Facial dystonia: clinical features, prognosis and pharmacology in 31 patients.

Authors:  G Defazio; P Lamberti; V Lepore; P Livrea; E Ferrari
Journal:  Ital J Neurol Sci       Date:  1989-12

9.  Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia.

Authors:  Laura M Scorr; Michael R Silver; John Hanfelt; Elaine Sperin; Alan Freeman; H A Jinnah; Stewart A Factor
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 10.  Current role of functional MRI in the diagnosis of movement disorders.

Authors:  Fatta B Nahab; Mark Hallett
Journal:  Neuroimaging Clin N Am       Date:  2010-02       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.